Skin cancer in Australia
Table 1 shows the latest national incidence count of melanoma, as provided by the Australian Institute of Health and Welfare (AIHW), and the number of paid Medicare services for non-melanoma skin cancers (NMSC: basal cell carcinoma, squamous cell carcinoma) based on Medicare records. The latest mortality statistics for melanoma and NMSC are provided as reported by the Australian Bureau of Statistics (ABS) for 2015.
According to the latest ABS data, of the Australians living with cancer in 2011-12, nearly one in three (32.6%) had skin cancer, making this the most common type of cancer. Medicare records show there are over 950,000 paid Medicare services for non melanoma skin cancers each year – more than 2,500 treatments each day.
At least 2 in 3 Australians will be diagnosed with skin cancer before the age of 70. The risk is higher in men than in women (70% vs. 58% cumulative risk of NMSC before age 70; 60 vs. 39 age-standardised incidence rate of melanoma.) The risk of mortality is also higher for men - 67% of Australians who die from skin cancer are men.
Skin cancer causes more deaths than transport accidents every year in Australia.
Table 1 Australian incidence and mortality for non-melanoma skin cancer (NMSC) and melanoma
|NMSC (number of paid Medicare services, not people*) 2014||600,482||358,761||959,243|
NMSC mortality includes deaths from the common skin cancers (SCC & BCC) and deaths from the rarer variants like Merkel cell tumours, dermatofibroma protuberans, and others.
Although ABS data show that skin cancer mortality rates have increased since 2000 (Figure 2.1), recent trends in Australia suggest stablisation or slight decline among those under the age of 45 years in melanoma and non-melanoma skin cancer incidence rates. This is consistent with earlier observations of stable incidence trends among young people in Australia, who are likely to have reduced their UV radiation exposure as a consequence of long-running public education campaigns to improve sun protection. A similar pattern has been observed for several other high-risk countries including New Zealand, North America, Israel and Norway. These recent changes illustrate the importance of decreased UV exposure in childhood as a key contributor in lowering skin cancer risk later in life.
Figure 1 Mortality rates in Australia 1982 to 2016.
Melanoma incidence and mortality
Melanoma of the skin is the third most commonly diagnosed cancer in males (after prostate and bowel cancer) and females (after breast and bowel cancer) In Australia. In 2016, an estimated 13,280 new cases of melanoma will be diagnosed in Australia, and 1,770 people will die.
Table 2 Australian incidence and mortality of melanoma
In Australia, the age-standardised incidence rate for melanoma increased by 181% between 1982 and 2016, from 27 cases per 100,000 to an estimated 49 cases per 100,000. However, how much of this increase is due to a real increase in the underlying disease, and how much is due to improved detection methods, is unknown. The incidence of melanoma of the skin rose at around 5.0% per year during the 1980s, moderating to 2.8% per year after that up until 2010. It is predicted that the initial rapid increase is partly attributable to individual behaviour and the use of solariums, resulting in increased exposure to solar ultraviolet radiation. The moderated trend after the 1980s is consistent with increased awareness of skin cancer and improved sun protective behaviours as a result of extensive skin cancer prevention programs dating back to the 1980s.
Australian women have a 1 in 24 chance of being diagnosed with melanoma before the age of 85, whereas men have a 1 in 14 risk of being diagnosed with melanoma before the age of 85, based on 2011 AIHW figures.
The age-standardised incidence rate of melanoma increased from 1982 to 2016, with this increase more marked for men than women (a 214% vs. 150% increase). There were an estimated 60 cases per 100,000 males and 39 cases per 100,000 women in 2016.
It is expected that melanoma in men will continue to increase to about 74 cases diagnosed per 100,000 men in 2020, equating to approximately 10,780 cases per annum. Among women it is expected that melanoma will continue to increase slowly to about 45 new cases diagnosed per 100,000 women in 2020, equating to approximately 6,790 cases per annum. The largest increase in rates of both genders is expected to occur at the age of 65 and above. It should be noted that these projections have been extrapolated from 1982-2007 incidence trends and do not take into account the future impact of skin cancer prevention campaigns, or the impact of reduced solarium use.
Gender differences are also observable in relation to mortality. Overall, Australians have a 1 in 129 chance of dying from melanoma by age 85 – men have a 1 in 84 chance and women a 1 in 240 chance.
Death rates for melanoma among men increased from 6.4 deaths per 100,000 in 1982 to an estimated 9.4 deaths per 100,000 in 2016; however, most of this increase occurred before 2005, and rates have remained fairly stable over the past decade. In women there was a negligible change from 3.2 deaths per 100,000 in 1982 to an estimated 3.6 deaths per 100,000 in 2016.
There is an observable age gradient for melanoma incidence according to AIHW data:
- 9.2% of people diagnosed with melanoma are aged under 40 years;
- 11.2% are aged 40-49;
- 18.4% are aged 50-59;
- 24.4% are aged 60-69;
- 20.4% are aged 70-79; and
- 16.3% are aged 80 or older.
The mean age for melanoma diagnosis is 63 years among men and 60 years among women.
While only a small proportion of total melanoma cases are diagnosed in people under 35 years of age, Australian adolescents have by far the highest incidence of malignant melanoma in the world (one-third of cancers in females, one-quarter in males), compared with adolescents in other countries. Furthermore, melanoma is the most common cancer diagnosed in Australians aged 15-29 years, and accounts for more than one-quarter of all cancers in this age group. However, research in Queensland suggests a decline in the incidence of thin invasive melanoma since the mid- to late 1990s among young people who have been exposed to Queensland’s primary prevention and early detection programs since birth.
Australia’s high incidence of skin cancer is attributable to a combination of its predominantly fair-skinned population and high levels of ambient UV radiation due to proximity to the equator.
According to 2012 IARC and WHO data, New Zealand has a slightly higher age-standardised incidence rate than Australia (35.8 vs. 34.9 per 100, 000 people), and mortality rate (4.7 vs. 4.0 per 100, 000). Melanoma incidence rates in Australia and New Zealand are more than two to three times higher than those in Canada, the United States and the United Kingdom. Although mortality rates are quite low, they are still more than two times higher in Australia and New Zealand than in Canada, the United States, and the United Kingdom.
However, there is promising data that suggests a recent stabilisation or slight decline in melanoma incidence rates in Australia over the last 10 years.
Within Australia, people in Queensland face the highest risk of developing melanoma, followed by Western Australia, New South Wales, Tasmania, Australian Capital Territory, Victoria, South Australia, and Northern Territory.
In Australia, there is no clear association of melanoma with socioeconomic status. The mortality rate is highest in the second and third lowest socioeconomic groups, and lowest in the highest socioeconomic group.
In 2005–2009, data from New South Wales, Queensland, Western Australia and the Northern Territory shows that the incidence of melanoma was 9.3 cases per 100,000 among Indigenous Australians, compared with 33 cases per 100,000 among non-Indigenous Australians. Mortality rates were also lower for Indigenous Australians (2.3 deaths per 100,000) compared with non-Indigenous Australians (6.4 deaths per 100,000).
Non-melanoma incidence and mortality
Although skin cancer accounts for 81% of all new cases of cancer diagnosed in Australia each year, it is often reported that breast cancer is the most common cancer in women and prostate cancer is the most common in men. That’s because most Australian cancer registries don’t routinely collect data for these more common forms of skin cancer – only the most serious, melanoma. Non-melanoma skin cancers (NMSC) are often self-detected and are usually removed in doctors’ surgeries, sometimes without histological confirmation due to destructive treatment techniques, or treatment with topical creams where tumour sites are only excised in post-treatment testing.
As the latest incidence data is estimated from self-reported, histologically confirmed (81.5%) and unconfirmed, NMSC treated in 2002, Medicare service numbers are provided as a proxy measure below.
Table 3: Australian incidence and mortality of Non-Melanoma Skin Cancers
|Incidence||2014 (number of paid Medicare services, not people*)||600,482||358,761||959,243|
|Incidence per 100,000||2002 (estimated from survey)||1,531||1,036||1,271|
NMSC mortality includes deaths from the common skin cancers (SCC & BCC) and deaths from the rarer NMSCs like Merkel cell tumours, dermatofibroma protuberans etc.
Non-melanocytic skin cancer accounted for 959,243 paid Medicare services in 2014 as evaluated from data on NMSC excisions, curettage, laser, or liquid nitrogen cryotherapy treatments.
Findings from the annual BEACH surveys of general practice conducted from 2006 to 2016 showed that skin cancer predominated as the cancer most often managed (by way of medications, clinical and procedural treatments, ordering of pathology or imaging tests) in GP-patient encounters, and was consistently among the top ten conditions managed by GPs.
Despite the high incidence rate of non-melanoma skin cancer, the age-standardised mortality rates are relatively low at 2.8 deaths per 100,000 population for males and 1.1 deaths per 100,000 for females.
According to the Australian Institute of Health and Welfare, skin cancer cost the health system over $400 million in 2008-9 ($367.37m non-melanoma and $49.5m melanoma) - the highest cost to the system of all cancers.
In Australia, relative survival after diagnosis of melanoma of the skin is very high when compared with other types of cancer. In 2007-2011, individuals with melanoma of the skin had a 90% chance of surviving for at least five years compared with the general population. Increases in melanoma survival were seen between 1980s and 1990s, 5-year survival increased from 86% in the period 1982-1987 to 91% in 1994-1999, however since the 2000s melanoma survival has stabilised. 
In the period 2007-2011:
- Five-year relative survival was greater for women compared with men (94% cf. 88%).
- Survival was high for all age groups, gradually declining with age (95% 5-year survival for those below 40 years as compared with 80% for those aged 80 years and over).
- Although survival was high overall it varied considerably by tumour thickness. Five-year survival was almost 100% for small tumours (1mm or less), but only 54% for large tumours thicker than 4mm.
- No significant differences in survival by remoteness or by socioeconomic status were observed.
Australian survival rates from melanoma are generally higher than in other countries due to the high proportion of thin lesions, according to the Cancer Epidemiology Centre at Cancer Council Victoria. Survival rates are higher in countries where there is greater melanoma awareness due to earlier detection.
As it is not mandatory to report non-melanoma skin cancers—more common, but far less deadly than melanoma—to cancer registries, incidence and prevalence statistics are not routinely available. As a consequence, there is no corresponding five-year survival data for non-melanoma skin cancer.
- Australian Bureau of Statistics. National health survey: Summary of results. Health service usage and health related actions. [homepage on the internet] Canberra, Australia: Australian Bureau of Statistics; 2013 Mar 26 [cited 2016 Oct 10]. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/826366E0BD2E8F16CA257B39000F3011?opendocument.
- Australian Institute of Health and Welfare. Skin cancer in Australia. Cat. no. CAN 96. Canberra, Australia: AIHW; 2016 [cited 2016 Oct 5] Available from: http://www.aihw.gov.au/publication-detail/?id=60129555786.
- Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006 Jan 2;184(1):6-10 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16398622.
- Australian Bureau of Statistics. 3303.0 Causes of death, Australia 2015. [homepage on the internet] Canberra, Australia: Australian Bureau of Statistics; 2016 Sep 28 [cited 2016 Oct 5]. Available from: http://www.abs.gov.au/Causes-of-Death.
- National Cancer Control Initiative. The 2002 national non-melanoma skin cancer survey. A report by the NCCI non-melanoma skin cancer working group. Melbourne, Australia; 2003.
- Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk? Int J Cancer 2013 Jan 15;132(2):385-400 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22532371.
- Olsen CM, Williams PF, Whiteman DC. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011. J Am Acad Dermatol 2014 Mar 28 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24685358.
- Australian Institute of Health and Welfare. Cancer in Australia: An overview, 2014. AIHW cat.no. CAN 88. Canberra, Australia; 2014 Available from: www.aihw.gov.au.
- Australian Institute of Health and Welfare. Australia’s health 2014. Australia’s health series no. 14. Cat. no. AUS 178. Canberra, Australia: Australian Institute of Health and Welfare; 2014 Available from: http://www.aihw.gov.au/publication-detail/?id=60129547205.
- Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001 Oct;63(1-3):8-18 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/11684447.
- Cust AE, Armstrong BK, Goumas C, Jenkins MA, Schmid H, Hopper JL, et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011 May 15;128(10):2425-35 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/20669232.
- Australian Institute of Health and Welfare. Cancer incidence projections, Australia 2011 to 2020. Canberra, Australia: Australian Institute of Health and Welfare; 2012 Available from: http://www.aihw.gov.au/publication-detail/?id=10737421461&tab=2.
- Stiller CA. International patterns of cancer incidence in adolescents. Cancer Treat Rev 2007 Nov;33(7):631-45 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/17329031.
- Australian Institute of Health and Welfare. Cancer in adolescents and young adults in Australia. Canberra, Australia; 2011 Available from: http://www.aihw.gov.au/publication-detail/?id=10737420603%20.
- Iannacone MR, Youlden DR, Baade PD, Aitken JF, Green AC. Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia. Int J Cancer 2014 May 8 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24806428.
- Liley JB, McKenzie RL. Where on earth has the highest UV? In: UV radiation and its effects - an update. Dunedin, New Zealand; 2017 May 22.
- Cody R, Lee C. Behaviors, beliefs, and intentions in skin cancer prevention. J Behav Med 1990 Aug;13(4):373-89 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/2246784.
- Volkov A, Dobbinson S, Wakefield M, Slevin T. Seven-year trends in sun protection and sunburn among Australian adolescents and adults. Aust N Z J Public Health 2013 Feb;37(1):63-9 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/23379808.
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 Available from: http://globocan.iarc.fr.
- Australian Institute of Health and Welfare. Cancer in Australia 2001. Canberra, Australia: Australian Institute of Health and Welfare, Australasian Association of Cancer Registries; 2004 Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442454484.
- Australian Bureau of Statistics. 3303.0 - Causes of Death, Australia, 2013. Canberra, Australia: ABS; 2015 Mar 31 [cited 2015 Mar 31]. Report No.: 3303.0. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3303.0.
- Britt H, Miller GC, Bayram C, Henderson J, Valenti L, Harrison C, Pan Y, Charles J, Pollack AJ, Chambers T, Gordon J, Wong C.. A decade of Australian general practice activity 2006-07 to 2015-16. General practice series no.41. Sydney, Australia: Sydney University Press; 2016 [cited 2016 Oct 11] Available from: https://ses.library.usyd.edu.au/bitstream/2123/15482/5/9781743325162_ONLINE.pdf.
- Australian Institute of Health and Welfare. Health system expenditure on cancer and other neoplasms in Australia: 2008–09. Cancer series no. 81. Cat. no. 78. Canberra, Australia: AIHW; 2013 [cited 2016 Oct 11] Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129545609.
- Australian Institute of Health and Welfare. Unpublished data from AIHW Disease Expenditure Database. Canberra, Australia: AIHW; 2013 [cited 2016 Oct 11] Available from: http://www.aihw.gov.au/expenditure-data/.
- Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust 2012 Nov 19;197(10):565-8 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/23163687.
- Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra, Australia; 2012 Available from: http://www.aihw.gov.au/publication-detail/?id=10737422720.
- Thursfield V, Giles G. Canstat No. 44: Skin cancer. Melbourne, Australia: Cancer Council Victoria; 2007 Nov.
- Australian Institute of Health and Welfare. Non-melanoma skin cancer: general practice consultations, hospitalisation and mortality. Canberra, Australia; 2008 Available from: http://www.aihw.gov.au/publication-detail/?id=6442468158.